FOXO3 and breast carcinoma: Two recent studies reported two additional direct miR-155 targets, FOXO3a (15) and suppressor of cytokine signaling 1 (29), respectively, both of which function as protective factors in breast cancer patients, demonstrating that this miRNA acts as an oncomiR in breast cancer.